Optimi Health Corp OPTHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OPTHF is a good fit for your portfolio.
News
-
Optimi Health Provides Corporate Update
-
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
-
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research
-
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
-
Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute
-
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
-
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
-
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University
Trading Information
- Previous Close Price
- $0.28
- Day Range
- $0.26–0.27
- 52-Week Range
- $0.11–0.43
- Bid/Ask
- $0.21 / $0.29
- Market Cap
- $23.10 Mil
- Volume/Avg
- 22,294 / 13,474
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 129.36
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 9
- Website
- https://www.optimihealth.ca
Valuation
|
Metric
|
OPTHF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.48 |
Price/Sales | 129.36 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
OPTHF
|
|---|---|
Quick Ratio | 0.74 |
Current Ratio | 1.85 |
Interest Coverage | −38.66 |
Quick Ratio
OPTHF
Profitability
|
Metric
|
OPTHF
|
|---|---|
Return on Assets (Normalized) | −31.63% |
Return on Equity (Normalized) | −35.76% |
Return on Invested Capital (Normalized) | −33.39% |
Return on Assets
OPTHF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Wxkdxkpqzm | Kcb | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Cpdnppvcwy | Pnjqrf | $72.9 Bil | |
HLN
| Haleon PLC ADR | Ntpmfcdg | Qdnr | $37.5 Bil | |
VTRS
| Viatris Inc | Msyptjrq | Zjdc | $13.3 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jttcfpqq | Mslwc | $11.7 Bil | |
CTLT
| Catalent Inc | Qsngnrx | Rhtkkp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Lchnvqm | Bwlgd | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Czctwys | Pvls | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jbxwxrvl | Nggnvxd | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Nzmnwdyyl | Wbbtq | $3.0 Bil |